Immunome, Inc.
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Job Posting Salary Data
From 2 marketing roles posted in the last 12 months
Community Salary Data
Help build salary transparency at Immunome, Inc.. Share your compensation anonymously.
Reviews
Jobs
About Immunome, Inc.
Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2008
- Headquarters
- Bothell
Why Work at Immunome, Inc.?
Discover what makes Immunome, Inc. a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
